Coronavirus information

Visitor restrictions, information for patients and more.

View coronavirus information

FOI 4631 Neuroendocrine tumours

Home > FOI Requests > Patient Data > FOI 4631 Neuroendocrine tumours

August 5, 2016

Last updated: August 5, 2016

  1. In your trust, please provide the number of patients treated in the last 12 months who have been diagnosed [any diagnosis position] with neuroendocrine tumours

15

  1. Of these how many have carcinoid syndrome (E34.0)?

None

  1. Of the patients with neuroendocrine tumours (NETs), how many received with the following treatments:
  • Somatuline Autogel (lanreotide)
  • Somatuline LA (lanreotide)
  • Sandostatin LAR (octreotide LAR)
  • Octreotide
  • Afinitor (everolimus)
  • Sutent (sunitinib)

None

 

  1. Please provide the number of patients treated in the last 12 months who have been diagnosed [any diagnosis position] with acromegaly (ICD10 code E220 or ICD10 code D352), with the following treatments:
  • Somatuline Autogel (lanreotide)
  • Somatuline LA (lanreotide)
  • Sandostatin LAR (octreotide LAR)
  • Octreotide
  • Somavert (pegvisomant)
  • Signifor (pasireotide pamoate)

None

 

Thinking of going to Accident and Emergency but not sure if you need to? Try our handy symptom checker.

Try ask A&E

We're improving the accessibility of our websites. If you can't access any content or if you would like to request information in another format, please view our accessibility statement.